ロード中...
PHARMACOGENETICS OF INTRAVENOUS AND ORAL BUSULFAN IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS
Kinetics-based dose targeting is often conducted in hematopoietic cell transplant (HCT) patients conditioned with intravenous (IV) or oral busulfan to lower rates of rejection, nonrelapse mortality, and relapse. Using the candidate gene approach, we evaluated whether busulfan clearance was associate...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3117932/ https://ncbi.nlm.nih.gov/pubmed/21135089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0091270010382915 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|